Document Detail


α-Adrenergic vasoconstrictor responsiveness is preserved in the heated human leg.
MedLine Citation:
PMID:  20693291     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study tested the hypothesis that passive leg heating attenuates α-adrenergic vasoconstriction within that limb. Femoral blood flow (FBF, femoral artery ultrasound Doppler) and femoral vascular conductance (FVC, FBF/mean arterial blood pressure), as well as calf muscle blood flow (CalfBF, ¹³³xenon) and calf vascular conductance (CalfVC) were measured during intra-arterial infusion of an α₁-adrenoreceptor agonist, phenylephrine (PE, 0.025 to 0.8 μg kg₋₁ min₋₁) and an α₂-adrenoreceptor agonist, BHT-933 (1.0 to 10 μg kg₋₁ min₋₁) during normothermia and passive leg heating (water-perfused pant leg). Passive leg heating (∼46◦C water temperature) increased FVC from 4.5 ± 0.5 to 11.9 ± 1.3 ml min₋₁ mmHg₋₁ (P < 0.001). Interestingly, CalfBF (1.8±0.2 vs. 2.8±0.3mlmin₋₁ (100 g)₋₁) and CalfVC (2.0±0.3 vs. 3.9±0.5mlmin₋₁ (100 g)₋₁ mmHg₋₁ ×100) were also increased by this perturbation (P <0.05 for both). Infusion of PE and BHT-933 resulted in greater absolute decreases in FVC during leg heating compared to normothermic conditions (maximal decreases in FVC during heating vs. normothermia: PE: 7.8 ± 1.1 vs. 2.8 ± 0.5 ml min₋₁ mmHg₋₁; BHT-933: 8.6 ± 1.7 vs. 2.1 ± 0.4 ml min₋₁ mmHg₋₁; P < 0.01 for both). However, the nadir FVC during drug infusion was higher during passive leg heating compared to normothermic conditions (FVC at highest dose of respective drugs during heating vs. normothermic conditions: PE: 3.7 ± 0.4 vs. 2.0 ± 0.3 ml min₋₁ mmHg₋₁; BHT-933: 3.8 ± 0.2 vs. 2.1 ± 0.3 ml min₋₁ mmHg₋₁; P < 0.001 for both). Leg heating did not alter the responsiveness of CalfBF or CalfVC to either PE or BHT-933. Taken together, these observations suggest that local heating does not decrease α-adrenergic responsiveness.However, heat-induced vasodilatation opposes α-adrenergic vasoconstriction. Furthermore, passive heating of a limb causes not only an increase in skin blood flow but also in muscle blood flow.
Authors:
David M Keller; Mikael Sander; Bente Stallknecht; Craig G Crandall
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of physiology     Volume:  588     ISSN:  1469-7793     ISO Abbreviation:  J. Physiol. (Lond.)     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-06     Completed Date:  2011-01-21     Revised Date:  2012-04-27    
Medline Journal Info:
Nlm Unique ID:  0266262     Medline TA:  J Physiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  3799-808     Citation Subset:  IM    
Affiliation:
Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, TX 75231, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-1 Receptor Agonists / pharmacology
Adrenergic alpha-2 Receptor Antagonists / pharmacology
Adrenergic alpha-Agonists / pharmacology
Adult
Azepines / pharmacology
Blood Pressure / physiology
Body Temperature / physiology
Dose-Response Relationship, Drug
Hot Temperature*
Humans
Leg / blood supply*
Male
Muscle, Skeletal / blood supply,  physiology
Phenylephrine / pharmacology
Receptors, Adrenergic, alpha / drug effects,  physiology*
Regional Blood Flow / drug effects,  physiology
Ultrasonography, Doppler
Vasoconstriction / drug effects,  physiology*
Xenon Radioisotopes / diagnostic use
Young Adult
Grant Support
ID/Acronym/Agency:
84072//PHS HHS; NHLBI 082426//PHS HHS; NHLBI 61388//PHS HHS; R01 HL061388-08/HL/NHLBI NIH HHS; R01 HL061388-09/HL/NHLBI NIH HHS; R01 HL061388-12/HL/NHLBI NIH HHS; R01 HL084072-02/HL/NHLBI NIH HHS; R01 HL084072-03/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Adrenergic alpha-1 Receptor Agonists; 0/Adrenergic alpha-2 Receptor Antagonists; 0/Adrenergic alpha-Agonists; 0/Azepines; 0/Receptors, Adrenergic, alpha; 0/Xenon Radioisotopes; 36067-73-9/B-HT 933; 59-42-7/Phenylephrine
Comments/Corrections
Comment In:
J Physiol. 2010 Oct 15;588(Pt 20):3847-8   [PMID:  20952374 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cholinergic modulation of excitatory synaptic input integration in hippocampal CA1.
Next Document:  The effect of passive movement training on angiogenic factors and capillary growth in human skeletal...